---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-051455"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:48:19.010110+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Werewolf Therapeutics cuts 64% of workforce; CFO and CMO depart; appoints new principal financial officer

## Summary
- Reduction in force affecting 64% of workforce; expected completion by Feb 13, 2026.
- Estimated one-time charge of ~$4.1 million in Q1 2026 for severance and benefits.
- CFO Timothy Trost and CMO Randi Isaacs resign effective Feb 13, 2026; enter 6-month consulting agreements at $250/hour.
- Michael Urban named principal financial and accounting officer, effective Feb 13, 2026.
- Company evaluating strategic alternatives for WTX-124 and WTX-330 programs; no assurance of transaction.

## SEC filing metadata
- accession: 0001193125-26-051455
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.05, 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000119312526051455/0001193125-26-051455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000119312526051455/d110809d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-051455
- JSON: https://secwatch.observer/filing/0001193125-26-051455.json
- Plain text: https://secwatch.observer/filing/0001193125-26-051455.txt

## Source-grounded claims
- claim_id: 48b7ed2b878de751916e47f7bb5ad8b2b9990eb1
  claim: Werewolf Therapeutics, Inc. announced a restructuring with charges of approximately $4.1 million (64% of the Company’s workforce).
  evidence_excerpt: estimates that it will record a one-time charge in the first quarter of 2026 related to employee separation benefits, including severance and related benefits, of approximately $4.1 million, all of which is anticipated to result in cash expenditures to be incurred in the first quarter of 2026. The Company may also incur additional costs not currently contemplated
  evidence_url: https://www.sec.gov/Archives/edgar/data/1785530/000119312526051455/0001193125-26-051455-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.